資源描述：
《CIK逆轉(zhuǎn)耐順鉑人肺腺癌細胞對順鉑耐藥與ERCC1的相關(guān)性-論文.pdf》由會員上傳分享，免費在線閱讀，更多相關(guān)內(nèi)容在應用文檔-天天文庫。
1、第23071卷4年第6月3期遵義醫(yī)學院學報V01．37No．3JournalofZunyiMedicalUniversityJun．2014CIK逆轉(zhuǎn)耐順鉑人肺腺癌細胞對順鉑耐藥與ERCC1的相關(guān)性田昕，李寧，李冉(遵義醫(yī)學院附屬腫瘤醫(yī)院胸部腫瘤科，貴州遵義563099)[摘要]目的觀察臍血來源的CIK細胞對A549／DDP細胞的耐藥逆轉(zhuǎn)作用。并探討CIK逆轉(zhuǎn)耐藥機制是否與核苷酸切除修復交叉互補基因1(excisionrepaircrosscomplementationgroup1，ERCC1)的
2、表達存在相關(guān)性。方法采集臍血單個核細胞經(jīng)細胞因子體外誘導獲得CIK細胞(cytokineinducedkillerceils，CIK)，MIrr法檢測順鉑(cisplatin，DDP)對A549細胞和A549／DDP細胞的體外殺傷作用，以及CIK細胞與A549／DDP細胞共培養(yǎng)前后對DDP敏感性的變化。Real—timeRT—PCR法檢測A549細胞、A549／DDP細胞以及CIK干預后的A549／DDP細胞中ERCC1mRNA的表達情況。Westernblot法檢測A549細胞、A549／DDP
3、細胞以及CIK干預后的A549／DDP細胞中ERCC1蛋白的表達情況。結(jié)果A549／DDP細胞對DDP耐藥，耐藥指數(shù)為2．391。CIK細胞能逆轉(zhuǎn)A549／DDP細胞對DDP的耐藥性，逆轉(zhuǎn)倍數(shù)為3．967。Real—timeRT—PCR、West—ernblot測得A549／DDP細胞中ERCC1mRNA和蛋白表達量比A549細胞高(P<0．05)，CIK細胞共培養(yǎng)前后A549／DDP細胞中ERCC1mRNA和蛋白表達量無明顯變化。結(jié)論CIK細胞能逆轉(zhuǎn)A549／DDP細胞對DDP的耐藥性，其逆轉(zhuǎn)耐
4、藥的機制與ERCC1的表達無明顯相關(guān)性。[關(guān)鍵詞]肺癌；A549細胞；順鉑；耐藥逆轉(zhuǎn)；CIK細胞[中圖法分類號]R734．2[文獻標志碼]A[文章編號]1000—2715(2014)03-0338-05StudyonthecorrelationbetweenERCC1andthemerchanismsunderlyingcy·tokineinducedkillercells——reversedcisplatinresistanceinA549／DDPCellsTianXin，LNing，LiRan
5、(DepartmentofThoracic，TheAffiliatedHospitalofZunyiMedicalUniversity，ZunyiGuizhou563099，China)[Abstract]ObjectiveToinvestigatetheeffectsofcordblood—derivedcytokine—inducedkiller(CIK)cellsonreversingcisplatinresistanceintheDDP——resistanthumanlungadenoca
6、rcinomacelllineA549／DDPandobservewhethertherewascorrelationbetweentheseeffectsandexcisionrepaircrosscomplementationgroup1(ERCC1)expression．MethodsThesingleumbilicalcordbloodmononuclearcellwasinducedbycytokineinvitrotobe—comeCIKcells．MTFassaywasapplied
7、toevaluatethecytotoxicactivityofDDPagainstA549／DDPcellsandA549cellsinvitroandthesensitivityofA549／DDPcellsCIKtoDDPbeforeandaftertheco—culturewithCIK．ThemRNAandproteinexpressionsofERCC1inA549cells。A549／DDPcellsandA549／DDPco—culturedwithCIKcellsweredete
8、ctedbyreal—timeRT—PCRandwesternblotanalysis．ResultsTheA549／DDPcellswasresistanttoDDPwiththeresistanceindexof2．391．CIKcellsdecreaseddrugresistancetocisplatinwiththere．versalfoldof3．967．TheERCC1mRNAandproteinexprossionswerehigherinA549／DDPthanth
